These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9577446)

  • 1. Should third-generation cephalosporins be the empirical treatment of choice for severe community-acquired pneumonia in adults?
    Paterson DL; Playford EG
    Med J Aust; 1998 Apr; 168(7):344-8. PubMed ID: 9577446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
    Vergis EN; Indorf A; File TM; Phillips J; Bates J; Tan J; Sarosi GA; Grayston JT; Summersgill J; YU VL
    Arch Intern Med; 2000 May; 160(9):1294-300. PubMed ID: 10809032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status of diagnosis and treatment of community-acquired pneumonia in Shanghai revealed by a questionnaire analysis].
    Liu J; Zhang J; Cheng QJ; Xu JF; Jie ZJ; Jiao Y; Huang Y; Qu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Apr; 41(4):288-295. PubMed ID: 29690685
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for severe community-acquired pneumonia in the western world.
    Vegelin AL; Bissumbhar P; Joore JC; Lammers JW; Hoepelman IM
    Neth J Med; 1999 Sep; 55(3):110-7. PubMed ID: 10509069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT).
    Wiersinga WJ; Bonten MJ; Boersma WG; Jonkers RE; Aleva RM; Kullberg BJ; Schouten JA; Degener JE; van de Garde EMW; Verheij TJ; Sachs APE; Prins JM
    Neth J Med; 2018 Jan; 76(1):4-13. PubMed ID: 29380739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial investigation and treatment of the patient with severe community-acquired pneumonia.
    Ortqvist A
    Semin Respir Infect; 1994 Sep; 9(3):166-79. PubMed ID: 7831538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
    Pfaller MA; Ehrhardt AF; Jones RN
    Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia.
    Aspa J; Rajas O; de Castro FR
    Expert Opin Pharmacother; 2008 Feb; 9(2):229-41. PubMed ID: 18201146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic usage for initial empirical treatment of infections in hospitalized patients in West Germany.
    Knothe H
    Infection; 1991; 19(3):127-30. PubMed ID: 1889863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-acquired pneumonia in adults: initial antibiotic therapy.
    King DE; Pippin HJ
    Am Fam Physician; 1997 Aug; 56(2):544-50. PubMed ID: 9262534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aetiology and treatment of community-acquired pneumonia in adults: an historical perspective.
    Fass RJ
    J Antimicrob Chemother; 1993 Jul; 32 Suppl A():17-27. PubMed ID: 8407696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
    Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F
    Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime: a review of its use in the management of hospitalized patients with pneumonia.
    Chapman TM; Perry CM
    Am J Respir Med; 2003; 2(1):75-107. PubMed ID: 14720024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumonia. Patient profiles, choice of empiric therapy, and the place of third-generation cephalosporins.
    Leedom JM
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):57-65. PubMed ID: 1730186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
    Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM
    J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Would ampicillin alone again be enough for treating community-acquired pneumonias?].
    Bédos JP
    Presse Med; 1998 Sep; 27(28):1440-1. PubMed ID: 9793046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study.
    Brereton CJ; Lennon D; Browning S; Dunn E; Ferguson JK; Davis JS
    Int J Antimicrob Agents; 2018 Jun; 51(6):862-866. PubMed ID: 29410326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.